logo

For the Inventor, By the Inventor

Wayne, PA, United States of America

Theodore S Sulkowski

USPTO Granted Patents = 34

Average Co-Inventor Count = 2.6

ph-index = 5

Forward Citations = 115(Granted Patents)


Location History:

  • Narberth, PA (US) (1976)
  • Wayne, PA (US) (1976 - 2006)

Company Filing History:

goldMedal27 out of 1,567 
 
American Home Products Corporation
 patents
silverMedal5 out of 1,309 
 
Wyeth
 patents
bronzeMedal1 out of 1 
 
American Home Procucts Corporation
 patent
4. 1 out of 832,966 
Other
 patents

Years Active: 1976-2006

Loading Chart...
34 patents (USPTO):Explore Patents
1. 7135492 - 1,3-disubstituted-2- thioxo-imidazolidine-4,5-dione derivatives useful in the treatment of atherosclerosis (2006-11-14),
2. 7115620 - 1,3-disubstituted-2-thioxo-imidazolidine-4,5-diones as potassium channel openers (2006-10-03),
3. 6562814 - 3-thioxo-[1,2,4]-oxadiazinan-5-one derivatives (2003-05-13),
4. 6472430 - Amino thioxomethyl amino oxyacetic acid derivatives (2002-10-29),
5. 6448255 - Imidazo-isoquinolin-5-one derivatives, pyrimido-isoquinolin-6-one derivatives and imidazo-naphthyridin-5-one derivatives (2002-09-10),
6. 6444694 - Styryl benzimidazole derivatives (2002-09-03),
7. 6288100 - Benzimidazole derivatives (2001-09-11),
8. 5939435 - 2-substituted-1-acyl-1,2-dihydroquinoline derivatives (1999-08-17),
9. 5877324 - 2-(substituted sulfanyl)-3,5-dihydro-imidazol-4-one derivatives (1999-03-02),
10. 5861517 - 2-thioxo-imidazolidin-4-one derivatives (1999-01-19),
11. 5821372 - 2-thioxo-imidazolidin-4-one derivatives (1998-10-13),
12. 5807864 - 2-thioxo-tetrahydropyrimidin-4-one derivatives (1998-09-15),
13. 5783707 - 2-thioxo-imidazolidin-4-one derivatives (1998-07-21),
14. 5763473 - Use of 2-substituted benzimidazole as smooth muscle cell proliferation (1998-06-09),
15. 5719153 - 5H,8H-2-oxa-1,3,5,8-tetraaza-cyclopenta�b!-naphthalene-6,7-diones (1998-02-17),

Title: The Innovative Contributions of Theodore S. Sulkowski

Introduction: Theodore S. Sulkowski, based in Wayne, PA, is an accomplished inventor known for his significant contributions to the field of pharmaceuticals. With a total of 34 patents to his name, Sulkowski has been instrumental in developing innovative compounds that address health issues such as atherosclerosis.

Latest Patents: Among his recent patents, Theodore Sulkowski has developed a series of 1,3-disubstituted-2-thioxo-imidazolidine-4,5-dione derivatives that are useful in the treatment of atherosclerosis. These antiatherosclerotic compounds, known as Formula I, exhibit potential as potassium channel openers, providing promising solutions in cardiovascular medicine.

Career Highlights: Throughout his career, Sulkowski has worked with esteemed companies, including American Home Products Corporation and Wyeth. His expertise in medicinal chemistry and drug development has allowed him to focus on innovations that improve patient outcomes and contribute to advancing healthcare.

Collaborations: In his journey as an inventor, Theodore has collaborated with notable peers, including Hassan Mahmoud Elokdah and Sie-Yearl Chai. These partnerships fostered an environment of interdisciplinary collaboration, enhancing the scope and impact of their research in the field of pharmaceutical innovations.

Conclusion: Theodore S. Sulkowski's dedication to innovation and research in pharmacology is evident through his numerous patents. His work not only contributes to medical advancements but also sets a benchmark for future inventors in the pharmaceutical industry. With continued collaboration and research, Sulkowski’s contributions will likely lead to further breakthroughs in treating complex health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…